Meningitis serogroup W135 outbreak, Burkina Faso, 2002

Emerging Infectious Diseases

Volumn 13, Issue 6, 2007, Pages 920-923

  Nathan, Nicolas ^a   Rose, Angela M C ^a   Legros, Dominique ^a   Tiendrebeogo, Sylvestre R M ^b   Bachy, Catherine ^a   Bjørløw, Egil ^c,d   Firmenich, Peter ^e   Guerin, Philippe J ^a   Caugant, Dominique A ^d,f  

^a EPICENTRE   (France)

^b MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^c European Programme for Intervention Epidemiology Training   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURKINA FASO; CHILD; EPIDEMIC; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PASTOREX TEST; PERFORMANCE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROTYPE; VIRUS CULTURE;

EID: 34250003951     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1306.060940     Document Type: Article

References (14)

1. Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341-53.
2. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis. 2002;185:1596-605.
3. Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis. 2003;9:665-71.
4. Issa M, Molling P, Unemo M, Backman A, Mosaad M, Sulaiman N, et al. Neisseria meningitidis serogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj in 2000. Scand J Infect Dis. 2003;35:230-3.
5. Matsika-Claquin MD, Perrocheau A, Taha MK, Levy-Bruhl D, Renault P, Alonso JM, et al. Meningococcal W135 infection epidemics associated with pilgrimage to Mecca in 2000. Presse Med. 2001;30:1529-34.
6. Caugant DA, Høiby EA, Frøholm LO, Brandtzæg P. Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial. Scand J Infect Dis. 1996;28:149-53.
7. Taha MK. Simultaneous approach for nonculture PCR-based identifi cation and serogroup prediction of Neisseria meningitidis. J Clin Microbiol. 2000;38:855-7.
8. World Health Organization. Meningococcal disease, serogroup W135, Burkina Faso. Wkly Epidemiol Rec. 2002;77:152-5.
9. World Health Organization. Meningococcal meningitis. Wkly Epidemiol Rec. 2003;78:294-6.
10. Brown V, Moren A, Paquet C. Rapid health assessment of refugee or displaced populations. 2nd ed. Paris: Médecins sans Frontières; 1999. p. 28. 11. Riou JY, Guibourdenche M. Laboratory methods: Neisseria and Branhamella. Paris: Editions Pasteur; 1993.
11. Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol. 1997;63:3741-51.
12. Sanou I, Ouedrago-Traore R, Ki-Zerbo GA, Bicaba I, Kam L, Sangare L, et al. W135 meningococcal meningitis: study of 148 cases observed in 2002 and 2003 at the National Teaching Hospital of Ouagadougou, Burkina Faso. Med Trop (Mars). 2006;66:137-42.
13. Djibo S, Njanpop Lafourcade BM, Boisier P, Moussa A, Kobo G, Sidikou F, et al. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135. Trans R Soc Trop Med Hyg. 2006;100:573-8.
14. Borel T, Rose AM, Guillerm M, Sidikou F, Gerstl S, Djibo A, et al. High sensitivity and specificity of the Pastorex latex agglutination test for Neisseria meningitidis serogroup A during a clinical trial in Niger. Trans R Soc Trop Med Hyg. 2006;100:964-9.